High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study
- PMID: 21269475
- PMCID: PMC3045316
- DOI: 10.1186/1471-2334-11-28
High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study
Abstract
Background: There are limited data on the prevalence of multi-drug resistant tuberculosis (MDR-TB), estimated at 0.6-6.7%, in African children with tuberculosis. We undertook a retrospective analysis of the prevalence of MDR-TB in children with Mycobacterium tuberculosis (MTB) at two hospitals in Johannesburg, South Africa.
Methods: Culture-confirmed cases of MTB in children under 14 years, attending two academic hospitals in Johannesburg, South Africa during 2008 were identified and hospital records of children diagnosed with drug-resistant TB were reviewed, including clinical and radiological outcomes at 6 and 12 months post-diagnosis. Culture of Mycobacterium tuberculosis complex (MTB) was performed using the automated liquid broth MGIT™ 960 method. Drug susceptibility testing (DST) was performed using the MGIT™ 960 method for both first and second-line anti-TB drugs.
Results: 1317 children were treated for tuberculosis in 2008 between the two hospitals where the study was conducted. Drug susceptibility testing was undertaken in 148 (72.5%) of the 204 children who had culture-confirmed tuberculosis. The prevalence of isoniazid-resistance was 14.2% (n = 21) (95%CI, 9.0-20.9%) and the prevalence of MDR-TB 8.8% (n = 13) (95%CI, 4.8-14.6%). The prevalence of HIV co-infection was 52.1% in children with drug susceptible-TB and 53.9% in children with MDR-TB. Ten (76.9%) of the 13 children with MDR-TB received appropriate treatment and four (30.8%) died at a median of 2.8 months (range 0.1-4.0 months) after the date of tuberculosis investigation.
Conclusions: There is a high prevalence of drug-resistant tuberculosis in children in Johannesburg in a setting with a high prevalence of HIV co-infection, although no association between HIV infection and MDR-TB was found in this study. Routine HIV and drug-susceptibility testing is warranted to optimize the management of childhood tuberculosis in settings such as ours.
Figures
References
-
- Core data on epidemiology and response. SouthAfrica; Epidemiological Fact Sheet on HIV and AIDS.http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/globa... Accessed 21/5/2009.
-
- World Health Organization. Global tuberculosis control 2009: epidemiology, strategy, financing. Geneva; 2009. http://www.who.int/tb/publications/global_report/2009/pdf/full_report.pdf Accessed 19/1/2011.
-
- Global Project on Anti-Tuberculosis Drug Resistance Surveillance 2002-2007, Antituberculous drug resistance in the world Report no. 4, 2008. Tuberculosis and Lung Disease (WHO/UNION); 2008. p. 394.http://www.who.int/tb/publications/2008/drs_report4_26feb08.pdf
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
